Anthropic’s IPO Could Price Above Its $70–$78 Range — and the Valuation Could Pass $1.5 Trillion

Anthropic put a price on its stock-market debut on Tuesday 10 November 2026: 825 million Class A shares at $70 to $78, a listing on Nasdaq under the ticker ANT, and a valuation of up to about $1.4 trillion on a fully diluted basis. Less than a day later, the Financial Times reported that the company’s bankers expect to price the deal above that range — a move that would lift the valuation to $1.5 trillion or more and push the total raised past $100 billion.

Quick answer: Anthropic's bankers expect to price its IPO above the $70–$78 range after a covered book, the FT reports — valuation past $1.5 trillion before 18 November.

The speed of the turn is the story. A week ago, the coverage was about a valuation sliding as Anthropic prepared its roadshow. Now the first day of the roadshow has produced a covered book, demand several times the shares on offer, and bankers openly weighing a higher price. This article separates what is on file with the regulator from what is only reported, because the two are very different numbers this week.

What the filing actually says

The terms sit in Amendment No. 2 to Anthropic’s Form S-1, filed with the US Securities and Exchange Commission on 10 November 2026, alongside Anthropic’s own roadshow announcement the same day. The headline terms are:

TermWhat the filing says
Shares offered825 million Class A shares — 801.35 million new shares from Anthropic and 23.65 million from existing shareholders, from which Anthropic receives no proceeds
Price range$70 to $78 per share; gross proceeds of $57.75 billion to $64.35 billion
Underwriters’ optionA further 123.75 million shares (the greenshoe), which at $78 would take the offering to about $74 billion
Private placement$26 billion of non-voting Class N stock at the IPO price, bought by Google, Nvidia, Microsoft, AMD, Broadcom, Micron and TSMC
Valuation at the top of the rangeAbout $1.41 trillion fully diluted; about $1.02 trillion on the 13.09 billion shares outstanding after the deal
ListingNasdaq Global Select Market, ticker ANT; Goldman Sachs and Morgan Stanley lead the syndicate
Expected timetablePricing on 18 November, first trade on 19 November — reported by CNBC, citing people familiar with the plans; not stated in the filing

One set of numbers should not be quoted at all: a draft sent to banks late on Monday 9 November showed about 867 million shares at $70 to $80, for up to $69.3 billion. Anthropic withdrew it within hours, saying the pricing details were inaccurate. The filed version is smaller on both levers — about 42 million fewer shares and a top price $2 lower — and it is the only version that counts.

Where the $1.5 trillion figure comes from

The $1.5 trillion figure is not in any filing. It comes from the Financial Times, which reported late on Tuesday 10 November, citing five people familiar with the matter, that Anthropic’s bankers expect to raise the share price above the $70 to $78 range after strong first-day demand. On the filing’s roughly 17.98 billion fully diluted shares, a $1.5 trillion valuation implies a price of about $83 a share — roughly 7% above the top of the range, or about $1.09 trillion on shares outstanding.

The demand behind that expectation is reported by two outlets. CNBC reported on Tuesday that the book was already covered at the range on an allocable basis, with institutional demand stronger than for SpaceX at the same stage. Bloomberg reported on Wednesday 11 November that prospective investors had indicated interest in several times the number of shares on offer, citing people familiar with the deal. Anthropic has not commented on either report, and no new range has been filed — the 10 November S-1/A is still the latest filing.

For scale, Morningstar analysts put Anthropic’s fair equity value at $1.7 trillion, with a range of $500 billion to $3 trillion depending on how fast its tools are adopted, according to the FT. That is an analyst estimate, not a market price, and the width of the range says more than the midpoint does.

A week ago, the story was a valuation slide

This is a follow-up to our earlier coverage. On 8 November we reported that Anthropic’s IPO roadshow was expected the following week as its valuation slid — the expectation then was a listing that would come in below the figures discussed earlier in the year. The filed range and the first day of the roadshow have reversed that direction in less than a week: the range is now on paper, the book is covered, and the conversation has moved from how far the valuation had fallen to how far above the range the price might go.

The reversal is also a reminder of how fast this deal moves. The draft figures circulated on Monday were wrong within hours. Any number in this story that is not in the 10 November filing should be read as reported, not confirmed — and the confirmation, if it comes, will arrive as an amended filing, not as another newspaper report.

Why investors are paying up

The filing gives the demand a financial spine. Anthropic put its annualised revenue run rate at about $81 billion as of 31 October 2026, up $10 billion in a single month. Revenue for the first nine months of 2026 was $33.2 billion, against $2.5 billion a year earlier. At a $1.5 trillion fully diluted valuation, that run rate implies a price of roughly 18.5 times annualised revenue — a multiple that only makes sense if investors believe the growth rate, not just the current figure, holds.

The structure of the deal also tells a story. The $26 billion private placement means Anthropic’s own suppliers and customers are buying in at the IPO price: Google and Nvidia at about $10 billion each, AMD at $2.5 billion, and Broadcom, Micron and Microsoft at about $1 billion each, with TSMC at about $500 million. The seven co-founders are each selling about $250 million of stock in the offering. And the retail allocation is reported at about 20% of the shares, against a typical 5% to 10% for a US listing — with Schwab, Fidelity, Robinhood, SoFi, E*Trade and Trade-PMR named as the brokers selling to retail investors. Anthropic has also opened an Australian retail offer, which closes on 17 November.

The caution in the room

The same week the book filled, the Federal Reserve’s Vice Chair for Supervision, Michelle Bowman, warned that stock prices could face a large correction if returns on AI investment fall short of expectations. Speaking at the Council on Foreign Relations in Washington on 10 November, she said AI-related debt is on track to exceed $800 billion this year, and pointed to off-balance-sheet liabilities and circular financing arrangements that make counterparty risk harder to assess. Her warning is conditional — what could happen if revenue fails to keep up with sharply rising costs — not a prediction of a crash. But it is the other side of the IPO’s demand story, and it landed on the same news cycle.

Anthropic’s own filing carries a matching caution in numbers. The Times reports that the company’s future spending commitments are worth $895.4 billion, the bulk of it data-centre contracts that must be paid irrespective of usage. The IPO is, in part, a way to fund that bill: three of the company’s backers told the FT that Anthropic is focused on raising as much capital as possible through the listing to support its infrastructure spending, rather than simply maximising its headline valuation.

That framing matters for how to read the $1.5 trillion figure. A higher price raises more money for the buildout, and the buildout is the cost the market is being asked to underwrite. The valuation and the spending commitment are the same bet, seen from opposite sides.

What to watch before 18 November

Three things will settle whether the $1.5 trillion figure becomes real. First, any amended filing that raises the range — that is the only confirmation that counts, and none has been filed yet. Second, whether the book stays covered as the roadshow continues through the week; the first day’s demand is a signal, not a guarantee. Third, the pricing itself, expected on the evening of 18 November, with the first trade on Nasdaq the following day. Fidelity expects the registration statement to take effect that evening.

For readers following the deal, the cleanest test is the filing: if the range moves, the story moves with it. Until then, $70 to $78 is the price on paper, and $1.5 trillion is what bankers expect to charge above it.

Our take: filed, reported, or expected?

Every big number in this deal needs a label, because the labels are doing the work. Here is the status of each one as of 12 November 2026:

FigureStatus
$70–$78 range, 825 million shares, up to $64.35 billionFiled — S-1/A, 10 November 2026
$1.26–$1.41 trillion fully diluted; ~$1.02 trillion on shares outstandingFiled — same document, different share counts
$26 billion private placement (Google, Nvidia, Microsoft, AMD, Broadcom, Micron, TSMC)Filed — concurrent private placement at the IPO price
Book covered at the range; demand stronger than SpaceX at the same stageReported — CNBC, 10 November
Demand several times the shares on offerReported — Bloomberg, 11 November
Pricing 18 November, trading 19 November, ~20% retail allocationReported — CNBC, citing people familiar with the plans
Price above the range; valuation $1.5 trillion or more; total raised past $100 billionExpected — Financial Times, citing five people familiar with the matter; no new range filed
Morningstar fair value $1.7 trillion ($500 billion–$3 trillion range)Analyst estimate — per the FT

Three questions to ask before treating $1.5 trillion as real: has an amended filing raised the range? Who is actually buying — institutions filling the book, or the retail allocation doing the work? And what does the price imply per dollar of revenue — at $81 billion of annualised run rate, $1.5 trillion is about 18.5 times revenue, a multiple that assumes the growth curve bends up, not down. The IPO will be the first time a frontier AI lab’s valuation is tested in public, and the test starts with which of these labels changes first.

Frequently Asked Questions

When does Anthropic price its IPO?

Pricing is expected on the evening of Wednesday 18 November 2026, with the first trade on Nasdaq on Thursday 19 November under the ticker ANT. Those dates come from CNBC, citing people familiar with the plans — the filing itself does not state them.

What is the filed price range for Anthropic’s IPO?

$70 to $78 per share for 825 million Class A shares, raising $57.75 billion to $64.35 billion before expenses. Anthropic sells 801.35 million of those shares; existing shareholders sell 23.65 million, and Anthropic receives none of those proceeds.

Is the $1.5 trillion valuation confirmed?

No. The Financial Times reported on 10 November, citing five people familiar with the matter, that bankers expect to price the deal above the $70–$78 range, which would lift the valuation to $1.5 trillion or more on a fully diluted basis. No new range has been filed with the SEC, and Anthropic has not commented.

How much is Anthropic raising in total?

Up to $64.35 billion from the public offering, plus $26 billion from a concurrent private placement, for up to $90.4 billion combined. With the underwriters’ greenshoe and an above-range price, the FT says the total raised could pass $100 billion.

Can ordinary investors buy Anthropic shares in the IPO?

About 20% of the shares are targeted at retail investors, according to CNBC — well above the typical 5% to 10%. The filing names Schwab, Fidelity, Robinhood, SoFi, E*Trade and Trade-PMR as retail brokers; Fidelity requires $25,000 in assets and a 100-share minimum, while Robinhood, SoFi and E*Trade have no minimum.

Sources and methodology

Claims in this article rest on Anthropic’s Amendment No. 2 to Form S-1, filed 10 November 2026, as reported by Dealroom and MLQ.ai’s summary of the Financial Times report; the FT’s above-range pricing report as carried by Business Standard; Bloomberg’s demand report via Wrivid; and Fed Vice Chair Michelle Bowman’s 10 November Council on Foreign Relations speech via JBizNews. Internal links: our 8 November roadshow piece, our METR acceleration explainer, and our Anthropic FlashProve explainer. Every figure is labelled filed, reported, expected or estimated; the $83-a-share and 18.5-times-revenue figures are our own arithmetic from the published numbers. Verified 12 November 2026. Desk-researched, not hands-on tested — this is a market story, and no investment advice is offered.

Leave a Reply

Your email address will not be published. Required fields are marked *